Having health insurance is a strong determinant of cancer outcomes in the United States, and Medicaid expansion under the Patient Protection and Affordable Care Act (ACA) may have reduced the prevalence of uninsured patients. Prior research has only assessed the aggregate effects of expansions, and little is known about changes in uninsured patients by state and key sociodemographic groups, including sex, race/ethnicity, census tract-level poverty, and rurality.
H aving health insurance is one of the strongest indicators of outcomes among patients with cancer in the United States. 1 The Patient Protection and Affordable
Care Act (ACA) contained multiple provisions to improve health insurance coverage, including expansion of state Medicaid program eligibility in 2014. Not all states opted to expand Medicaid coverage, however. National surveillance data show that the implementation of the ACA brought the uninsured rate among Americans to a record low: 9.0% in the first 9 months of 2017 compared with 16 .0% in 2010 when the ACA was signed into law. 2 Because increased insurance eligibility may improve access to cancer screening, diagnostic follow-up, and treatment, several studies [3] [4] [5] have explored the effects of Medicaid expansions on insurance and early-stage diagnosis in patients with cancer. A recent study 3 that used the National Cancer Database reported substantial reductions in the percentage of uninsured among nonelderly patients with cancer in 2014 in Medicaid expansion states in aggregate. Significant, albeit smaller, reductions in the percentage of uninsured patients were observed among patients residing in nonexpansion states. 3 Another study 4 used the Surveillance, Epidemiology, and End Results (SEER) Program cancer registry data from 13 states and found a slightly increased percentage of uninsured patients in the nonexpansion states. Both data sources showed an increase in early-stage cancer diagnosis in 2014. 3, 5 These studies [3] [4] [5] assessed only the aggregate effects of Medicaid expansion, and little is known about the extent of changes in the percentage of uninsured patients by state and key sociodemographic groups, including sex, race/ethnicity, census tract-level poverty, and rurality. We extended those previous studies 3-5 using a newly available population-based cancer registry data set from 40 states provided by the North American Association of Central Cancer Registries (NAACCR) to examine changes in the uninsured rate and the percentage of early-stage diagnoses after implementation of the ACA by state and sociodemographic groups.
Methods

Patients
The NAACCR compiles cancer incidence data from member registries in North America that meet all quality and completeness requirements. 6 The data are used in population-based descriptive cancer epidemiologic studies, including the Annual Report to the Nation on the Status of Cancer. 7, 8 Insurance status is a required NAACCR field. With improvements in uniformity and data completeness, this field recently became available to researchers. 9, 10 In this study, we included cancer cases from population-based registries of 40 states that had more than 85% completeness for the health insurance field. Specifically, we obtained information on 2 471 154 patients aged 18 to 64 years with a new diagnosis of a first primary malignant cancer from January 1, 2010, to December 31, 2014, from 21 Medicaid expansion states (n = 1 234 156) and 19 nonexpansion states (n = 1 236 998). These states account for more than 80% of the cancer population in the United States. 11 Patients were categorized by sex, race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, and other), census tract-level poverty (<5%, 5%-9.9%, 10%-19.9%, or ≥20% of persons below the federal poverty line), and rurality (rural, urban) according to residence at the time of diagnosis. Stage at diagnosis was categorized as 0/I (early), II to IV (late), or unknown according to the seventh edition of the American Joint Committee Classification (AJCC). 12 In the analysis of stage at diagnosis, 712 774 patients diagnosed with cancers without applicable AJCC staging scheme or from registries in which the missing rate of stage was 15% or higher were excluded (eTable 1intheSupplement), leaving 1 758 380 patients from 34 states in the stage analysis. The study was based on deidentified database data and exempt from institutional review board and informed consent by the NAACCR Institutional Review Board.
Statistical Analysis
We calculated the percentage of uninsured patients by calendar year for each state and socioeconomic subgroup by states' Medicaid expansion status. The percentage of uninsured patients by sex was examined among racial/ethnic groups. We used standard statistical approaches for evaluating the influence of health policy changes in quasi-experimental studies. [13] [14] [15] [16] The changes in the percentage of uninsured before (January 1, 2010, to December 31, 2013) and after (January 1, 2014, to December 31, 2014) implementation of the ACA was calculated for each state and socioeconomic subgroup. We conducted difference-in-differences (DD) analyses to assess the association of the ACA with the percentage of uninsured patients, with patients from nonexpansion states serving as the control group and patients from expansion states as the intervention group. Crude and multivariable linear probability models were fitted, adjusting for age, sex, state, race/ethnicity, census tract-level poverty, and rurality when applicable. Sensitivity analysis that excluded patients from Michigan (expanded Medicaid eligibility on April 1, 2014) or New Hampshire (expanded Medicaid eligibility on August 15, 2014) showed similar results (eTable 2 in the Supplement). Sensitivity analysis that included only cases from 29 states that had more than 90% completeness of the health insurance field did not change the findings (eTable 3 in the Supplement). The data analyses were conducted from November 2017 to April 2018.
Similarly, the changes in the percentage of early-stage diagnoses before and after ACA implementation were calculated, and DD analysis was conducted to examine the association between Medicaid expansion and shifts in stage at diagnosis for all cancers combined and for the 20 most common cancers in the nonelderly population. The changes in percentage of early-stage diagnoses for all cancer combined were also calculated by state and sociodemographic factors. SEER*Stat, version 8.3.4, and SAS statistical software, version 9.4 (SAS Institute Inc), were used to perform the analyses. Wald χ 2 tests were used, and a 2-sided P < .05 was considered to be statistically significant. Table 2 and eFigure 1 in the Supplement provide the changes in the percentage of uninsured patients by year before and after implementation of the ACA for each of the 40 states. The percentage of uninsured patients decreased in almost all states, although the decreases were substantially higher in expansion than nonexpansion states (eFigure 2 in the Supplement), especially in expansion states with high baseline uninsured rates. For example, the percentage of uninsured patients decreased from 8.3% before implementation of the ACA to 2.1% after implementation of the ACA in the expansion state of Kentucky but from only 9.1% to 7.6% in the neighboring nonexpansion state of Tennessee. Similarly, the percentage of uninsured patients decreased from 9.6% to 4.0% in the expansion state of Arkansas but from only 10.4% to 8.8% in the neighboring nonexpansion state of Mississippi. Table 3 provides DD estimates of changes in the percentage of uninsured patients overall and by sociodemographic groups. Overall, after adjustment for sociodemographic factors, Medicaid expansion states experienced a 1.3-percentage point (ppt) greater reduction in the percentage of uninsured patients compared with the nonexpansion states (crude 2.6 vs 1.0 ppt; P < .001). In Medicaid expansion states, the reduction in the percentage of uninsured patients was larger among males than females (2.8 vs 2.4 ppt), especially among Hispanic patients (4.5 vs 3.6 ppt) (eFigure 3 in the Supplement), minority groups (>4 ppt for non-Hispanic blacks and Hispanics vs 2.3 ppt for nonHispanic whites), those living in higher census tract-level poverty areas (4.6 ppt for the lowest-income individuals vs 1.3 ppt for the highest-income individuals), and rural residents (4.3 ppt for rural vs 2.5 ppt for urban), resulting in narrowing or elimination of disparities among the groups.
Results
In contrast, the reductions in the percentage of uninsured patients in nonexpansion states were small (approximately 1 ppt) and similar across sociodemographic subgroups, and sociodemographic disparities remained high (Table 3 , Figure, and eFigure 4 in the Supplement). As a result, disparities in the percentage of uninsured patients between expansion states and nonexpansion states within each subpopulation increased, most prominently among those who were socioeconomically disadvantaged (eFigure 5 in the Supplement). For example, before implementation of the ACA, the percentage of uninsured patients in nonexpansion states was 4.9 ppt higher than that in expansion states among those living in the lowest-income census tracts, and this difference widened to 8.5 ppt in 2014; similarly, the difference among rural residents widened from 2.1 ppt to 5.6 ppt after implementation of the ACA (Table 3 ). In addition, the difference in the percentage of uninsured patients between those residing in the lowest-income neighborhoods in expansion states and in affluent neighborhoods in nonexpansion states was nearly eliminated after implementation of the ACA, from 4.7 ppt to 0.9 ppt (Table 3) . Table 4 gives the DD estimates of changes in the percentage of early-stage diagnoses for all cancers combined and for the most common cancer sites. Medicaid expansion was associated with a slight but significant (0.4 ppt) increase in the percentage of early-stage diagnosis for all cancers combined. For colorectal, lung, and female breast cancer, which can be detected through screening (and covered by most insurers without patient cost sharing), and for melanoma, which can be detected through early symptoms, the percentage of earlystage diagnoses increased in both expansion and nonexpansion states, but the differences between expansion and nonexpansion states were not significant. Significant shifts to early stage in expansion states compared with nonexpansion states were observed for only non-Hodgkin lymphoma (adjusted DD, 1.8 ppt) and pancreatic cancer (adjusted DD, 1.5 ppt). For liver cancer, a significant 2.7-ppt decrease in earlystage diagnosis was observed in expansion states compared with nonexpansion states. The highest shift to early-stage diagnosis for all cancers occurred in the expansion states of Oregon and Connecticut and the nonexpansion state of Maine (eTable 1 in the Supplement). Few changes in sociodemographic disparities in stage at diagnosis were observed in the first year of Medicaid expansion (eTable 4 in the Supplement).
Discussion
Using population-based cancer registry data for nearly 2.5 million patients with new cancer diagnoses from 40 states during 2010 to 2014, we found that the percentage of uninsured patients decreased in almost all states after implementation of the ACA in 2014. However, the decreases were substantially greater in expansion than nonexpansion states and were greatest in expansion states with high baseline uninsured rates, such as Kentucky, Arkansas, and Oregon. In expansion states, the decrease in the percentage of uninsured patients were larg- Our finding of diminishing racial/ethnic disparities in the percentage of uninsured patients among those diagnosed with cancer is similar to previous findings among the general population of narrowing racial/ethnic disparities in noninsurance and access to care after implementation of the ACA. 19 However, the narrowing in racial/ethnic disparities among the general population was seen in both Medicaid expansion states and nonexpansion states, whereas in our study of patients with cancer, the narrowing of disparities was seen only in Medicaid expansion states. This finding suggests that marketplace exchanges, which were available nationwide, may have led to reduced racial/ ethnic disparities in nonexpansion states among the general population, but this effect might be minimal among the population of patients with cancer, which tends to be older and have higher baseline insurance rates. Even before implementation of the ACA, residents of nonexpansion states were more likely to be uninsured and to have worse access to care, lower preventive services use, and higher out-of-pocket medical costs than were residents of expansion states. 10, 20 The emerging widening disparity in the percentage of uninsured patients between the nonexpansion and expansion states after implementation of the ACA will likely exacerbate the inequalities in access to care and health outcomes because of differential state policies in expanding Medicaid eligibility.
Although it may take a longer time to observe any association of reduced noninsurance with cancer treatment, survival, and financial hardship, using these 1-year post-ACA data, we found a small yet significant shift to early-stage cancer diagnosis associated with Medicaid expansion for all cancers combined, non-Hodgkin lymphoma, and pancreatic cancer. Our patient-level findings are consistent with recent research that evaluated the aggregate effects of Medicaid expansions using the National Cancer Database and SEER and reported shifts or increases in early-stage diagnoses in expansion states. 3, 5 Taken together, these findings suggest improved access to screening services and symptom assessment in expansion states. However, the changes in stage at diagnosis should be interpreted with caution and warrant future monitoring. There are several possible reasons for the small changes observed and null findings of other cancer types. First, power to detect differences might be small for specific cancer types because of the short period after implementation of the ACA. The DD estimates for most cancer types were positive although not statistically significant. Second, the influence of Medicaid expansion may be diluted by the large number of national and local programs that provide breast, cervical, and colorectal cancer screening for low-income, uninsured and underinsured populations, such as the Centers for Disease Control and Prevention's National Breast and Cervical Cancer Early Detection Program 21 and the Colorectal Cancer Control Program.
22
Third, the decrease in percentage of early-stage diagnoses of prostate cancer and cervical cancer may reflect the changes in screening guidelines, for which the recommendation of routine prostate-specific antigen testing was discontinued 23 and the recommended frequency of Papanicolaou tests was reduced. 24 However, the difference in early-stage diagnosis of liver cancer between expansion and nonexpansion states may reflect differences in surveillance for persons at high risk of the disease, those with cirrhosis, and those with chronic hepatitis B infection. Fourth, increases in insurance coverage may be necessary but not sufficient to guarantee improvements in access to care and quality of care. The type of health insurance coverage is also important. For example, a recent study 25 from California found that improvements in cancer survival from 1997 to 2014 were limited to patients with private or Medicare insurance but not public insurance at diagnosis. Patients with cancer may gain public insurance coverage at cancer diagnosis and then lose eligibility for insurance coverage after completion of initial treatment, with adverse effects on access to high-quality survivorship care. In addition to encouraging states to expand eligibility for Medicaid, the ACA also has provisions to improve care quality for Medicaid enrollees, such as providing funding to support medical homes, increasing primary care payment rates, and promoting preventive services and vaccinations. 26 It is important to monitor disparities in stage at diagnosis and other long-term ; thus, future studies that evaluate the changes and disparities in health outcomes within Medicaid expansion states will be of great interest.
Strengths and Limitations
A strength of our study is the use of population-based cancer registry data for nearly 2.5 million patients with newly diagnosed cancer from 40 states to examine changes in insurance coverage after implementation of the ACA by state. However, our study is limited by availability of only 1 year of post-ACA data, and we could not assess changes for late Medicaid expansion states, including Pennsylvania (January 1, 2015), Indiana (February 1, 2015) , Alaska (September 1, 2015), Montana (January 1, 2016), Louisiana (July 1, 2016), Maine (to be determined), and Virginia (January 1, 2019) . 28 Future studies with more recent data are warranted to monitor the changes in these states. Moreover, future studies are needed to examine the effects of the ACA on changes in care for cancer survivors, for whom we were not able to examine gains in insurance coverage or access to care using the incidence data from cancer registries.
Conclusions
We found large state variation in reductions in the percentage of uninsured patients among nonelderly patients with cancer after implementation of the ACA, with larger decreases in expansion vs nonexpansion states and in socioeconomically disadvantaged vs nondisadvantaged patients. Disparities in the percentage of uninsured patients by race/ ethnicity, census tract-level poverty, and rurality were diminished or eliminated for patients in Medicaid expansion states but remained high in nonexpansion states, suggesting that Medicaid expansion may be an effective strategy in mitigating health disparities. Future studies that monitor the effect of Medicaid expansion on cancer outcomes and health disparities are warranted. 
